JGP Global Gestao de Recursos Ltda.
In its 13F for Q4 2024 (holdings as of December 31, 2024, filed January 24, 2025), JGP Global Gestao de Recursos Ltda. reported 39 stock positions worth $43.9 million. Its top holding was New Gold (NGD) at 36.7% of the portfolio, followed by Stoneco Class A (STNE, 13.9%) and Eli Lilly (LLY, 4.2%). Compared with Q3 2024, it opened 7 new positions, sold out of 7, added to 2 and reduced 21. The biggest buy was New Gold (NGD, shares +28%) and the biggest sale Stoneco Class A (STNE, shares −29%).
- Most Recent 13F
- Q2 2026
- Location
- RIO DE JANEIRO, D5
- CIK
- 0001536562
- Portfolio Value
- $43.9M (Q4 2024)
- SEC Filing
- 0001536562-25-000002 ↗ filed Jan 24, 2025
Holdings Value
Holdings 39 stocks · $43.9M
| NGD New Gold Inc. | 36.71% | 6,500,000 | $16.1M | Add +27.8% |
| STNE Stoneco Ltd. Class A | 13.88% | 764,797 | $6.1M | Reduce -29.5% |
| LLY Eli Lilly & Co. | 4.20% | 2,387 | $1.8M | Reduce -0.1% |
| ONC Beone Medicines Ltd.-ADR filed as BEIGENE LTD | 3.94% | 9,374 | $1.7M | Reduce -0.0% |
| INCY Incyte Corp. | 3.87% | 24,633 | $1.7M | No change |
| ISRG Intuitive Surgical Inc. | 3.34% | 2,810 | $1.5M | Add +45.5% |
| TEO Telecom Argentina SA-SP ADR | 1.94% | 67,751 | $853K | New |
| BMA Banco Macro SA-ADR | 1.90% | 8,617 | $834K | New |
| GGAL Grupo Financiero Galicia-ADR | 1.87% | 13,150 | $820K | New |
| YPF YPF S.A.-Sponsored ADR filed as YPF SOCIEDAD ANONIMA | 1.86% | 19,210 | $817K | New |
| LOMA Loma Negra Cia Ind-Spon ADR | 1.79% | 65,786 | $785K | New |
| TMO Thermo Fisher Scientific Inc. | 1.68% | 1,422 | $740K | Reduce -0.1% |
| UNH Unitedhealth Group Inc. | 1.59% | 1,380 | $698K | Reduce -39.0% |
| SYK Stryker Corp. | 1.53% | 1,862 | $670K | Reduce -0.1% |
| ACAD Acadia Pharmaceuticals Inc. | 1.45% | 34,620 | $635K | No change |
| ARGX Argenx SE - ADR | 1.40% | 1,002 | $616K | Reduce -0.1% |
| MDGL Madrigal Pharmaceuticals Inc. | 1.40% | 1,993 | $615K | No change |
| DHR Danaher Corp. | 1.29% | 2,472 | $567K | Reduce -0.1% |
| MRK Merck & Co. Inc. | 1.29% | 5,695 | $567K | Reduce -0.1% |
| AEM Agnico Eagle Mines Ltd. | 1.16% | 6,497 | $508K | No change |
| ELV Elevance Health Inc. | 1.03% | 1,226 | $452K | Reduce -0.1% |
| INSM Insmed Inc. | 0.96% | 6,120 | $423K | Reduce -0.1% |
| VRTX Vertex Pharmaceuticals Inc. | 0.89% | 968 | $390K | Reduce -0.1% |
| REGN Regeneron Pharmaceuticals | 0.87% | 538 | $383K | Reduce -0.2% |
| AZN Astrazeneca PLC-Spons ADR | 0.86% | 5,762 | $378K | Reduce -0.1% |
| ALNY Alnylam Pharmaceuticals Inc. | 0.83% | 1,546 | $364K | Reduce -0.1% |
| AMGN Amgen Inc. | 0.81% | 1,361 | $355K | Reduce -0.1% |
| RVMD Revolution Medicines Inc. | 0.77% | 7,704 | $337K | Reduce -0.0% |
| BSX Boston Scientific Corp. | 0.73% | 3,605 | $322K | Reduce -0.1% |
| SMMT Summit Therapeutics Inc. | 0.69% | 17,080 | $305K | No change |
| RYTM Rhythm Pharmaceuticals Inc. | 0.69% | 5,378 | $301K | Reduce -90.5% |
| AGI Alamos Gold Inc. Class A | 0.65% | 15,452 | $285K | No change |
| CI The Cigna Group | 0.57% | 911 | $252K | Reduce -0.1% |
| KYMR Kymera Therapeutics Inc. | 0.55% | 5,991 | $241K | Reduce -0.0% |
| PEN Penumbra Inc. | 0.49% | 901 | $214K | New |
| KOD Kodiak Sciences Inc. | 0.29% | 12,950 | $129K | No change |
| ABCL Abcellera Biologics Inc. | 0.15% | 22,598 | $66K | No change |
| CERS Cerus Corp. | 0.06% | 15,963 | $25K | No change |
| OI SA filed as OI SA-ADR | 0.03% | 50,301 | $13K | New |
Options reported separately and not counted above: SGML puts ($25K).
Portfolio Sells Q3 2024 → Q4 2024
| STNE Stoneco Ltd. Class A | Reduce -29.5% | 13.88% | −10.03 |
| RYTM Rhythm Pharmaceuticals Inc. | Reduce -90.5% | 0.69% | −5.10 |
| ITUB Itau Unibanco H-Spon PRF ADR | Sold out | 0.00% | −2.58 |
| UNH Unitedhealth Group Inc. | Reduce -39.0% | 1.59% | −1.00 |
| GDX Vaneck Gold Miners ETF | Sold out | 0.00% | −0.61 |
| NVO Novo-Nordisk A/S-Spons ADR | Sold out | 0.00% | −0.51 |
| HCA HCA Healthcare Inc. | Sold out | 0.00% | −0.46 |
| MOH Molina Healthcare Inc. | Sold out | 0.00% | −0.41 |
| BPMC Blueprint Medicines Corp. | Sold out | 0.00% | −0.40 |
| BDX Becton Dickinson and Co. | Sold out | 0.00% | −0.40 |
| REGN Regeneron Pharmaceuticals | Reduce -0.2% | 0.87% | −0.24 |
| ELV Elevance Health Inc. | Reduce -0.1% | 1.03% | −0.22 |
| ONC Beone Medicines Ltd.-ADR | Reduce -0.0% | 3.94% | −0.18 |
| DHR Danaher Corp. | Reduce -0.1% | 1.29% | −0.05 |
| AMGN Amgen Inc. | Reduce -0.1% | 0.81% | −0.05 |
| CI The Cigna Group | Reduce -0.1% | 0.57% | −0.05 |
| TMO Thermo Fisher Scientific Inc. | Reduce -0.1% | 1.68% | −0.04 |
| AZN Astrazeneca PLC-Spons ADR | Reduce -0.1% | 0.86% | −0.02 |
| KYMR Kymera Therapeutics Inc. | Reduce -0.0% | 0.55% | −0.01 |
| ALNY Alnylam Pharmaceuticals Inc. | Reduce -0.1% | 0.83% | −0.01 |
| VRTX Vertex Pharmaceuticals Inc. | Reduce -0.1% | 0.89% | +0.01 |
| MRK Merck & Co. Inc. | Reduce -0.1% | 1.29% | +0.02 |
| LLY Eli Lilly & Co. | Reduce -0.1% | 4.20% | +0.05 |
| RVMD Revolution Medicines Inc. | Reduce -0.0% | 0.77% | +0.08 |
| INSM Insmed Inc. | Reduce -0.1% | 0.96% | +0.09 |
| BSX Boston Scientific Corp. | Reduce -0.1% | 0.73% | +0.14 |
| SYK Stryker Corp. | Reduce -0.1% | 1.53% | +0.21 |
| ARGX Argenx SE - ADR | Reduce -0.1% | 1.40% | +0.34 |
Portfolio Buys Q3 2024 → Q4 2024
| NGD New Gold Inc. | Add +27.8% | 36.71% | +8.01 |
| TEO Telecom Argentina SA-SP ADR | New | 1.94% | +1.94 |
| BMA Banco Macro SA-ADR | New | 1.90% | +1.90 |
| GGAL Grupo Financiero Galicia-ADR | New | 1.87% | +1.87 |
| YPF YPF S.A.-Sponsored ADR | New | 1.86% | +1.86 |
| LOMA Loma Negra Cia Ind-Spon ADR | New | 1.79% | +1.79 |
| ISRG Intuitive Surgical Inc. | Add +45.5% | 3.34% | +1.48 |
| PEN Penumbra Inc. | New | 0.49% | +0.49 |
| OI SA | New | 0.03% | +0.03 |
All Filings
| Quarter | Positions | 13F Reported Value | Top Holdings |
|---|---|---|---|
| Q2 2026 | 29 | $44.8M | XP, SPY, SFTBY, VEON, PROSY |
| Q1 2026 | 23 | $22.3M | STNE, XP, NU, LLY, ABBV |
| Q4 2025 | 44 | $168.9M | NGD, STNE, SOLS, RRC, NU |
| Q3 2025 | 32 | $171.4M | NGD, STNE, XP, NU, ONC |
| Q2 2025 | 45 | $204.3M | STNE, NGD, XP, KTOS, IBIT |
| Q1 2025 | 34 | $130.7M | STNE, NGD, PPLT, XP, CAPRI HOLDINGS LTD |
| Q4 2024 | 39 | $43.9M | NGD, STNE, LLY, ONC, INCY |
| Q3 2024 | 39 | $51.1M | NGD, STNE, RYTM, LLY, ONC |
| Q2 2024 | 41 | $78.8M | STNE, NU, CUCSF, DSKYF, SPGI |
| Q1 2024 | 58 | $155.5M | BYDDF, XP, STNE, NU, NGD |